Recent
price
P/E
ratio
div
yld
1.63%
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Here's How Abbott's EP Business Is Shaping Up for the Rest of 2026
Is ABT Overvalued? DCF Says Worth $76
11,649 Abbott Laboratories $ABT Shares Bought by AlTi Global Inc.
Abbott Laboratories $ABT Stock: Allworth Financial LP Increases Position
Should You Buy, Hold or Sell Abbott Stock Post-Q3 Earnings?
CenterBook Partners LP Acquires New Shares in Abbott Laboratories $ABT
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Can UltiSynq Lead Boost Abbott's Cardiac Rhythm Management Business?
3 Legacy Health Care Dividend Stocks That Never Go Out of Style
Abbott Laboratories $ABT Stock: Allen Investment Management LLC Reduces Stake
Ashton Thomas Private Wealth LLC Buys 5,216 Shares of Abbott Laboratories $ABT
3 Medical Device Stocks That Keep Raising Dividends. One Just Hit 55 Years
69 Dividend Champions Ranked By Quality Scores (November 2026)
Dividend Champion, Contender, And Challenger Highlights: Week of November 8
These 12 stocks are good bets to beat the 10-year Treasury over the next decade
99,391 Shares of Abbott Laboratories $ABT Bought by Associated Banc Corp
Abbott Laboratories $ABT Stock: Heritage Investors Management Corp Trims Holdings
Abbott Touts Favorable Outcomes In Cardiovascular Device Trials
Late-breaking one-year data show Abbott's next-generation Amulet 360™ device continues to demonstrate high rates of left atrial appendage closure and low incidence of stroke
2 Safe S&P 500 Healthcare Dividend Stocks Boomers Can Buy and Hold Forever